Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Frank McKeon
University of Houston, Department: Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
MultiClonal Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The PI owns (b)(4) equity; his spouse owns (b)(4)
The company has no monetary value at this point.
The PI and his spouse are on the Scientific Advisory Board, but have no decision-making authority and have received no monetary compensation for this role to date.
MultiClonal Therapeutics, Inc. is based on technology to clone stem cells of columnar epithelium. The ultimate goal of the company is to turn it into a reagent business to make systems available to pharmaceutical companies. The technology has already been validated and published, however because the investigator is using the technology as a research tool in his NIH-funded research to clone cancer precursor lesions, there could be the perception of a conflict.
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence
NA
Filed on February 02, 2018.
Tell us what you know about Frank McKeon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Frank McKeon filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Frank McKeon | University of Houston | Conflict of Interest | Tract Pharmaceuticals | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.